Larazotide(258818-34-7)
- Name: Larazotide
- Synonyms:15: PN:US20080103100 SEQID: 15 claimed protein; 15: PN: WO0007609 SEQID: 15 claimedsequence; 15: PN: WO0189551 SEQID: 15 claimed protein; 15: PN: WO2008043107SEQID: 15 claimed protein; 15: PN: WO2008073627 SEQID: 15 claimed protein; 15:PN: WO2009110947 SEQID: 15 claimed sequence; 1: PN: WO0015252 SEQID: 7 claimedprotein; 1: PN: WO2008150981 SEQID: 1 claimed protein; 1: PN: WO2008154493SEQID: 1 claimed protein; 1: PN: WO2009137572 SEQID: 1 claimed protein; 20: PN:WO2007095092 SEQID: 1 claimed sequence; 21: PN: WO2006135811 SEQID: 15 claimedprotein; 24: PN: WO2009006246 SEQID: 15 unclaimed protein; 3: PN: WO2005010022SEQID: 3 claimed sequence; AT 2347; Larazotide
- Molecular Formula:C32H55 N9 O10
- Molecular Weight:725.83
- CAS Registry Number:258818-34-7
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 379231-04-6/Saracatinib
- 857402-23-4/Retaspimycin
- 944548-37-2/rafivirumab
- 869884-78-6/Radezolid
- 410528-02-8/palovarotene
- 686344-29-6/Otenabant
- 181816-48-8/Ombrabulin
- 180694-97-7/Mimopezil
- 868771-57-7/Melogliptin
- 78246-90-9/Cyclopropanecarbonylchloride, 3-(2-chloro-3,3,3-trifluoro-1-propen-1-yl)-2,2-dimethyl-
- 441798-33-0/macitentan
- 116412-83-0/4-Chloro-3,4'-DimethoxyBenzophenone
- 320367-13-3/Lixisenatide
- 668270-12-0/Linagliptin
- 96847-55-1/Levomilnacipran
- 327026-93-7/Lensiprazine
- 258818-34-7/Larazotide
- 223132-37-4/inolitazone
- 464213-10-3/Ibipinabant
- 944548-38-3/Foravirumab
- 892553-42-3/Etaracizumab
- 98819-76-2/Esreboxetine
- 355129-15-6/Eprotirome
- 488832-69-5/Elesclomol
- 834153-87-6/elagolix
- 480449-70-5/Edoxaban
- 867153-61-5/dulanermin
- 187865-22-1/derquantel
- 716840-32-3/Denenicokin
- 827318-97-8/Danusertib